P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

MLA

Sebastiano Gili, et al. P2Y12 Inhibitors in Acute Coronary Syndrome Patients with Renal Dysfunction: An Analysis from the RENAMI and BleeMACS Projects. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e108272e5efb0a338b587a554d8ce5df&authtype=sso&custid=ns315887.

APA

Sebastiano Gili, Ioanna Xanthopoulou, Albert Ariza-Solé, Mario Iannaccone, Tetsuma Kawaji, Umberto Morbiducci, Ugo Fabrizio, Tim Kinnaird, Christoph Liebetrau, Toshiharu Fujii, Ferdinando Varbella, Isabel Muñoz Pousa, Mattia Peyracchia, Emad Abu-Assi, Christian Templin, Stephen B. Wilton, Diego Gallo, Ovidio De Filippo, Enrico Cerrato, … Fabrizio D’Ascenzo. (2020). P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.

Chicago

Sebastiano Gili, Ioanna Xanthopoulou, Albert Ariza-Solé, Mario Iannaccone, Tetsuma Kawaji, Umberto Morbiducci, Ugo Fabrizio, et al. 2020. “P2Y12 Inhibitors in Acute Coronary Syndrome Patients with Renal Dysfunction: An Analysis from the RENAMI and BleeMACS Projects,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e108272e5efb0a338b587a554d8ce5df&authtype=sso&custid=ns315887.